Atara Biotherapeutics, Inc.

ATRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 May 16, 2024
144 May 16, 2024
144 May 16, 2024
144 May 16, 2024
144 May 16, 2024
DEFR14A May 10, 2024 DEFR14A
10-Q May 9, 2024 10-Q
8-K May 9, 2024 8-K
DEFA14A Apr 26, 2024 DEFA14A
DEF 14A Apr 26, 2024 DEF 14A
PRE 14A Apr 12, 2024 PRE 14A
4 Apr 2, 2024
4 Apr 2, 2024
4 Apr 2, 2024
4 Apr 2, 2024
4 Apr 2, 2024
8-K Mar 29, 2024 8-K
10-K Mar 28, 2024 10-K
8-K Mar 28, 2024 8-K
SC 13G Mar 18, 2024 SC 13G
4 Mar 6, 2024
4 Mar 6, 2024
4 Mar 6, 2024
4 Mar 6, 2024
4 Mar 6, 2024
← Newer Page 8 of 46 · 1130 filings Older →